The Bioss Blog

News, updates, and analysis from the world of research. Interested in having your work with Bioss' products featured on the site? Email marketing@biossusa.com for more information.

Be sure to follow us on Twitter and Facebook for regular updates.

5 Tips for Reducing Non-specific Signal on Western Blots

Anyone who does western blots routinely knows the feeling: you test a new antibody and are filled with anticipation as your film lurches out of the X-OMAT. Seconds later, your hopes are crushed as you realize your samples have been lost to an uglyfalse

Bradykinin Receptor B1 as a Therapeutic Target in Lupus Nephritis

Systemic lupus erythematosus is a chronic autoimmune disorder that can affect nearly any organ system in the body. A common symptom is lupus nephritis, which occurs when the disease attacks the kidneys causing inflammation, one of the leading causesfalse

Bioss to Attend Immunology 2019 in San Diego

Bioss Antibodies is excited to be attending IMMUNOLOGY 2019, the 103rd Annual Meeting of the American Association of Immunologists, in San Diego from May 9 - 13. Our team will be in the exhibit hall Friday, Saturday, and Sunday at Booth 538.

Applying Nanolipidgels, Researchers Probe New Kidney Disease Target CaMK4

Podocytes, specialized cells named for their foot processes, play an essential role in kidney function. These cells line the capillaries of the glomerulus, the functional unit of filtration within the kidney, and are connected by junctions that aidfalse

An Unexpected Candidate in the Search for Liver Cancer Therapies

Hepatocellular carcinoma (HCC) — the most common primary liver cancer in adults — currently has poor prognosis in most patients. Previous research has shown that, by activating or silencing specific genes, researchers can gain insights into thefalse

Bioss to Attend AACR 2019 in Atlanta

The Bioss team is excited to be traveling to Atlanta, GA, at the end of March for the annual meeting of the American Association for Cancer Research. The meeting will take place from March 29 to April 3 at the Georgia World Congress Center.

In Search for ALS Therapies, Researchers Turn to Protein Interactions

Amyotrophic lateral sclerosis (ALS) — also known as Lou Gehrig’s disease — is a progression motor neuron disease characterized by loss of muscle tissue and impaired movement. The genetic underpinnings of the disease are complex and not understoodfalse